Filana Therapeutics FLNA
NASDAQ FLNA
$0.96 +0.02 (+1.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) FCF Margin (2010 - 2013)

Filana Therapeutics (FLNA) posted quarterly FCF Margin of 3.16% for Q4 2013, up 7196.0% year-over-year from 0.04% in Q4 2012, and up 96.6% quarter-over-quarter from 92.9% in Q3 2013.

Filana Therapeutics (FLNA) FCF Margin (2010 - 2013) Analysis & Trends

Filana Therapeutics' FCF Margin history runs 4 years deep, the most recent figure standing at 3.16% for Q4 2013.

  • In Q4 2013, FCF Margin rose 7196.0% year-over-year to 3.16%; the TTM figure through Dec 2013 stood at 16.07% (up 4978.0% YoY), while the FY2013 annual figure was 16.04%, up 4981.0% from the prior year.
  • FCF Margin for Q4 2013 stood at 3.16%, up from 92.9% in the prior quarter.
  • The five-year high for FCF Margin was 118.48% in Q3 2010, with the low at 95.66% in Q1 2013.
  • The 4-year median for FCF Margin is 51.9% (2011), against an average of 35.38%.
  • The sharpest annual moves came in 2012 and 2013: FCF Margin sank 17031 bps in 2012, then jumped 7196 bps in 2013.
  • Filana Therapeutics' FCF Margin stood at 41.69% in 2010, then gained by 29 bps to 29.49% in 2011, then plunged by 155 bps to 75.12% in 2012, then surged by 96 bps to 3.16% in 2013.
  • Business Quant data shows FLNA's FCF Margin at 3.16% in Q4 2013, 92.9% in Q3 2013, and 91.93% in Q2 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 13.35%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -388.28%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 25.68%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 22.62%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 41.07%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -22.35%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 70.82%
10 Filana Therapeutics 46.00 Mn 46.00 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.16%
Sep 30, 2013 -92.90%
Jun 30, 2013 -91.93%
Mar 31, 2013 -95.66%
Dec 31, 2012 -75.12%
Sep 30, 2012 -47.60%
Jun 30, 2012 -71.59%
Mar 31, 2012 -69.63%
Dec 31, 2011 -29.49%
Sep 30, 2011 -39.54%
Jun 30, 2011 -56.21%
Mar 31, 2011 100.68%
Dec 31, 2010 -41.69%
Sep 30, 2010 118.48%